deltatrials
Completed PHASE3 NCT01173809

Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation

Sponsor: California Pacific Medical Center

Conditions Atrial Fibrillation
Interventions Amiodarone
Updated 6 times since 2017 Last updated: Aug 20, 2014 Started: Oct 31, 2010 Primary completion: May 31, 2014 Completion: Jul 31, 2014

Listed as NCT01173809, this PHASE3 trial focuses on Atrial Fibrillation and remains completed. Sponsored by California Pacific Medical Center, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE3

    First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • California Pacific Medical Center
  • Case Western Reserve University
  • Catholic University, Italy
  • Southlake Regional Health Centre
  • Stanford University
  • Texas Cardiac Arrhythmia Research Foundation
  • University of Kansas
Data source: Texas Cardiac Arrhythmia Research Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Austin, United States